Reports
Sale
Latin America Multiplexed Diagnostics Market Size, Share: By Product Type: Reagents & Consumables, Instruments and Accessories, Others; By Application: Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies, Others; By Technology; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Latin America Multiplexed Diagnostics Market Size
The global multiplexed diagnostics market was valued at USD 12.9 billion in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for advanced diagnostic technologies. It is expected to grow at a CAGR of 15.2% during the forecast period of 2024-2032, with the values likely to attain USD 46.2 billion by 2032.
Latin America Multiplexed Diagnostics Market Outlook
- In July 2023, a study revealed that cardiovascular diseases (31.1%), cancer (30.6%), and respiratory diseases (8.6%) account for over two-thirds of deaths in South America. The rising burden of chronic and infectious diseases is expected to fuel the market demand in the region.
- One of the major Latin America multiplexed diagnostics market trends is the rising development of advanced multiplex diagnostics techniques. For instance, in July 2023 , a multiplex RT-qPCR one-step assay was developed by a team of Brazilian researchers to detect the hepatitis delta virus, a major health issue in endemic areas of South America.
- The growing focus of the government and private healthcare providers on upgrading the diagnostic capabilities in healthcare settings including cost-effective multiplexed diagnostics solutions is likely to boost the market share.
Latin America Multiplexed Diagnostics Market Analysis
Multiplexed diagnostics can simultaneously detect and analyze multiple biomarkers or pathogens in a single assay. It can diagnose various diseases, monitor treatment responses, and screen for genetic predispositions, all in a single test, thereby reducing the time and cost associated with running multiple individual tests. The rising technological advancements resulting in more precise and faster diagnoses of various medical conditions are significantly contributing to the Latin America multiplexed diagnostics market growth.
Latin American countries are experiencing serious health challenges from both chronic diseases and infectious diseases. In July 2023, a study including 24718 participants in Argentina, Brazil, Chile, and Colombia, revealed that cardiovascular diseases (31.1%), cancer (30.6%), and respiratory diseases (8.6%) account for over two-thirds of deaths in South America . Multiplexed diagnostics can help reduce the mortality rate associated with these diseases by efficiently and rapidly screening for various pathogens or biomarkers, improving disease management and control. Thus, the rising burden of chronic and infectious diseases is expected to fuel the Latin America multiplexed diagnostics market demand.
One of the major market trends is the rising development of highly efficient and reproducible multiplex diagnostics techniques. For instance, in July 2023, a team of Brazilian researchers developed a multiplex RT-qPCR one-step assay to detect the hepatitis delta virus, a major health issue in endemic areas of South America. In the diagnostic sensitivity tests, the assay showed an accuracy of 97.37% when compared to the reference test. For monitoring the hepatitis delta virus carriers and assessing disease progression, the assay demonstrated robust efficiency and precision, thus acting as a valuable diagnostic tool. Further, the increased healthcare expenditure and the rising focus of the government on upgrading diagnostic capabilities in healthcare settings are poised to boost the market share.
Latin America Multiplexed Diagnostics Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product Type | Reagents, Consumables, Instruments and Accessories, Others |
| Application | Infectious Disease, Oncology, Autoimmune Diseases, Cardiac Diseases, Allergies, Disease Diagnostics, Molecular Diagnostics, Others |
| Technology | Low Density Multiplexed Assays, Medium Density Multiplexed Assays, High Density Multiplexed Assays, Very High Density Multiplexed Assays, Next-Generation Sequencing Assays, Others |
| End User | Hospitals, Pharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Laboratories, Others |
| Countries | Brazil, Mexico, Argentina, Others |
Latin America Multiplexed Diagnostics Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd
- BioMerieux
- Illumina, Inc.
- Hologic, Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Siemens Healthineers AG
- Boston Scientific Corporation
- Diasorin S.p.A
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Application |
|
| Breakup by Technology |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Multiplexed Diagnostics Market Overview
3.1 Latin America Multiplexed Diagnostics Market Historical Value (2017-2023)
3.2 Latin America Multiplexed Diagnostics Market Forecast Value (2024-2032)
4 Latin America Multiplexed Diagnostics Market Landscape*
4.1 Latin America Multiplexed Diagnostics Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Multiplexed Diagnostics Market: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Material
4.2.3 Analysis by Type
5 Latin America Multiplexed Diagnostics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Multiplexed Diagnostics Market Segmentation (2017-2032)
6.1 Latin America Multiplexed Diagnostics Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Reagents & Consumables
6.1.3 Instruments and Accessories
6.1.4 Others
6.2 Latin America Multiplexed Diagnostics Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Infectious Disease
6.2.3 Oncology
6.2.4 Autoimmune Diseases
6.2.5 Cardiac Diseases
6.2.6 Allergies
6.2.7 Disease Diagnostics
6.2.8 Molecular Diagnostics
6.2.9 Others
6.3 Latin America Multiplexed Diagnostics Market (2017-2032) by Technology
6.3.1 Market Overview
6.3.2 Low Density Multiplexed Assays
6.3.3 Medium Density Multiplexed Assays
6.3.4 High Density Multiplexed Assays
6.3.5 Very High-Density Multiplexed Assays
6.3.6 Next-Generation Sequencing Assays
6.3.7 Others
6.4 Latin America Multiplexed Diagnostics Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Pharmaceutical Companies
6.4.4 Clinical Research Organizations
6.4.5 Academic Research Institutes
6.4.6 Diagnostic Laboratories
6.4.7 Others
6.5 Latin America Multiplexed Diagnostics Market (2017-2032) by Countries
6.5.1 Market Overview
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Others
7 Brazil Multiplexed Diagnostics Market (2017-2032)
7.1 Brazil Multiplexed Diagnostics Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Reagents & Consumables
7.1.3 Instruments and Accessories
7.1.4 Others
7.2 Brazil Multiplexed Diagnostics Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Infectious Disease
7.2.3 Oncology
7.2.4 Autoimmune Diseases
7.2.5 Cardiac Diseases
7.2.6 Allergies
7.2.7 Disease Diagnostics
7.2.8 Molecular Diagnostics
7.2.9 Others
7.3 Brazil Multiplexed Diagnostics Market (2017-2032) by Technology
7.3.1 Market Overview
7.3.2 Low Density Multiplexed Assays
7.3.3 Medium Density Multiplexed Assays
7.3.4 High Density Multiplexed Assays
7.3.5 Very High Density Multiplexed Assays
7.3.6 Next-Generation Sequencing Assays
7.3.7 Others
7.4 Brazil Multiplexed Diagnostics Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Academic Research Institutes
7.4.3 Hospitals
7.4.4 Pharmaceutical Companies
7.4.5 Clinical Research Organizations
7.4.6 Diagnostic Laboratories
7.4.7 Others
8 Argentina Multiplexed Diagnostics Market (2017-2032)
8.1 Argentina Multiplexed Diagnostics Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Reagents & Consumables
8.1.3 Instruments and Accessories
8.1.4 Others
8.2 Argentina Multiplexed Diagnostics Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Infectious Disease
8.2.3 Oncology
8.2.4 Autoimmune Diseases
8.2.5 Cardiac Diseases
8.2.6 Allergies
8.2.7 Disease Diagnostics
8.2.8 Molecular Diagnostics
8.2.9 Others
8.3 Argentina Multiplexed Diagnostics Market (2017-2032) by Technology
8.3.1 Market Overview
8.3.2 Low Density Multiplexed Assays
8.3.3 Medium Density Multiplexed Assays
8.3.4 High Density Multiplexed Assays
8.3.5 Very High-Density Multiplexed Assays
8.3.6 Next-Generation Sequencing Assays
8.3.7 Others
8.4 Argentina Multiplexed Diagnostics Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Academic Research Institutes
8.4.3 Hospitals
8.4.4 Pharmaceutical Companies
8.4.5 Clinical Research Organizations
8.4.6 Diagnostic Laboratories
8.4.7 Others
9 Mexico Multiplexed Diagnostics Market (2017-2032)
9.1 Mexico Multiplexed Diagnostics Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Reagents & Consumables
9.1.3 Instruments and Accessories
9.1.4 Others
9.2 Mexico Multiplexed Diagnostics Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Infectious Disease
9.2.3 Oncology
9.2.4 Autoimmune Diseases
9.2.5 Cardiac Diseases
9.2.6 Allergies
9.2.7 Disease Diagnostics
9.2.8 Molecular Diagnostics
9.2.9 Others
9.3 Mexico Multiplexed Diagnostics Market (2017-2032) by Technology
9.3.1 Market Overview
9.3.2 Low Density Multiplexed Assays
9.3.3 Medium Density Multiplexed Assays
9.3.4 High Density Multiplexed Assays
9.3.5 Very High Density Multiplexed Assays
9.3.6 Next-Generation Sequencing Assays
9.3.7 Others
9.4 Mexico Multiplexed Diagnostics Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Academic Research Institutes
9.4.3 Hospitals
9.4.4 Pharmaceutical Companies
9.4.5 Clinical Research Organizations
9.4.6 Diagnostic Laboratories
9.4.7 Others
10 Regulatory Framework
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Funding and Investment Analysis
12.1 Analysis by Funding Instances
12.2 Analysis by Type of Funding
12.3 Analysis by Funding Amount
12.4 Analysis by Leading Players
12.5 Analysis by Leading Investors
12.6 Analysis by Geography
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 Agilent technologies Inc
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 F. Hoffmann-La Roche Ltd
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 BioMerieux
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Illumina,Inc
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Hologic,Inc
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Thermo Fisher Scientific Inc
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Bio-Rad Laboratories Inc
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 Siemens Healthineers AG
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Boston Scientific Corporation
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic Reach and Achievements
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Diasorin S.p.A
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Latin America Multiplexed Diagnostics Market – Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Latin America multiplexed diagnostics market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 15.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 46.2 billion by 2032.
The rising prevalence of chronic and infectious diseases is fuelling the demand for the market.
One of the significant trends in the market is the rising development of advanced multiplex diagnostics techniques. For instance, in July 2023, a multiplex RT-qPCR one-step assay was developed by a team of Brazilian researchers to detect the hepatitis delta virus.
Based on the product type, the market is segmented into reagents, consumables, instruments, and accessories, among others.
Technologies available in the market include low density multiplexed assays, medium density multiplexed assays, high density multiplexed assays, very high-density multiplexed assays, and next-generation sequencing assays, among others.
End users of the market are hospitals, pharmaceutical companies, clinical research organizations, academic research institutes, and diagnostic laboratories, among others.
Major application areas include infectious disease, oncology, autoimmune diseases, cardiac diseases, allergies, disease diagnostics, and molecular diagnostics, among others.
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
The key players in the market are Agilent Technologies Inc., F. Hoffmann-La Roche Ltd, BioMerieux, Illumina Inc., Hologic Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Siemens Healthineers AG, Boston Scientific Corporation, and Diasorin S.p.A.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER